关注
Cornelia M. Keck
标题
引用次数
引用次数
年份
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation
CM Keck, RH Müller
European journal of pharmaceutics and biopharmaceutics 62 (1), 3-16, 2006
14272006
Challenges and solutions for the delivery of biotech drugs–a review of drug nanocrystal technology and lipid nanoparticles
RH Muller, CM Keck
Journal of biotechnology 113 (1-3), 151-170, 2004
11022004
State of the art of nanocrystals–special features, production, nanotoxicology aspects and intracellular delivery
RH Müller, S Gohla, CM Keck
European journal of pharmaceutics and biopharmaceutics 78 (1), 1-9, 2011
7972011
Production and characterization of Hesperetin nanosuspensions for dermal delivery
PR Mishra, L Al Shaal, RH Müller, CM Keck
International journal of pharmaceutics 371 (1-2), 182-189, 2009
3772009
Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure
A Kovacevic, S Savic, G Vuleta, RH Mueller, CM Keck
International journal of pharmaceutics 406 (1-2), 163-172, 2011
3562011
Development of an oral rutin nanocrystal formulation
R Mauludin, RH Müller, CM Keck
International journal of pharmaceutics 370 (1-2), 202-209, 2009
3112009
Natural nanoparticles: a particular matter inspired by nature
S Griffin, MI Masood, MJ Nasim, M Sarfraz, AP Ebokaiwe, KH Schäfer, ...
Antioxidants 7 (1), 3, 2017
2542017
Kinetic solubility and dissolution velocity of rutin nanocrystals
R Mauludin, RH Müller, CM Keck
European Journal of Pharmaceutical Sciences 36 (4-5), 502-510, 2009
2042009
Nanotoxicological classification system (NCS)–a guide for the risk-benefit assessment of nanoparticulate drug delivery systems
CM Keck, RH Müller
European Journal of Pharmaceutics and Biopharmaceutics 84 (3), 445-448, 2013
1922013
Size analysis of submicron particles by laser diffractometry—90% of the published measurements are false
CM Keck, RH Müller
International journal of pharmaceutics 355 (1-2), 150-163, 2008
1822008
Development of curcumin nanocrystal: physical aspects
H Rachmawati, L Al Shaal, RH Müller, CM Keck
Journal of pharmaceutical sciences 102 (1), 204-214, 2013
1762013
Preservation of nanostructured lipid carriers (NLC)
WM Obeidat, K Schwabe, RH Müller, CM Keck
European Journal of Pharmaceutics and Biopharmaceutics 76 (1), 56-67, 2010
1732010
Drug delivery to the brain–realization by novel drug carriers
RH Müller, CM Keck
Journal of nanoscience and nanotechnology 4 (5), 471-483, 2004
1532004
Twenty years of drug nanocrystals: where are we, and where do we go?
RH Müller, CM Keck
European journal of pharmaceutics and biopharmaceutics: official journal of …, 2011
1502011
Skin photoprotection improvement: synergistic interaction between lipid nanoparticles and organic UV filters
S Nikolić, CM Keck, C Anselmi, RH Müller
International journal of pharmaceutics 414 (1-2), 276-284, 2011
1292011
Nanostructured lipid carriers (NLC): the second generation of solid lipid nanoparticles
RH Müller, U Alexiev, P Sinambela, CM Keck
Percutaneous penetration enhancers chemical methods in penetration …, 2016
1252016
Solid lipid nanoparticles (SLN) stabilized with polyhydroxy surfactants: Preparation, characterization and physical stability investigation
AB Kovačević, RH Müller, SD Savić, GM Vuleta, CM Keck
Colloids and Surfaces A: Physicochemical and Engineering Aspects 444, 15-25, 2014
1192014
Resveratrol nanosuspensions for dermal application–production, characterization, and physical stability
S Kobierski, K Ofori-Kwakye, RH Müller, CM Keck
Die Pharmazie-An International Journal of Pharmaceutical Sciences 64 (11 …, 2009
1072009
Ultra-small NLC for improved dermal delivery of coenyzme Q10
JC Schwarz, N Baisaeng, M Hoppel, M Löw, CM Keck, C Valenta
International journal of pharmaceutics 447 (1-2), 213-217, 2013
1032013
Second generation of drug nanocrystals for delivery of poorly soluble drugs: smartCrystals technology
C Keck, S Kobierski, R Mauludin, RH Müller
Dosis 24 (2), 124-128, 2008
1032008
系统目前无法执行此操作,请稍后再试。
文章 1–20